Predictive significance of changes in dietary restraint in obese patients with binge eating disorder during treatment.
OBJECTIVE
To examine whether changes in different aspects of dietary restraint in obese patients with binge eating disorder (BED) participating in a treatment study predict outcomes.


METHODS
Fifty obese patients with BED in a randomized controlled study of orlistat administered with cognitive-behavioral therapy, guided-self-help (CBTgsh) completed dietary restraint measures at baseline, during- and post-treatment, and three-month follow-up.


RESULTS
Change in the restraint scale of the Eating Disorder Examination-Questionnaire did not predict binge abstinence or 5% weight loss. Increased flexible restraint subscale of the Three Factor Eating Questionnaire (TFEQ) during treatment significantly predicted binge abstinence at post-treatment and three-month follow-up and 5% weight loss at post-treatment. Change in the rigid restraint subscale of the TFEQ predicted binge abstinence at post-treatment.


CONCLUSIONS
Our findings clarify further pathologic and adaptive aspects of restraint and suggest the importance of enhancing flexible restraint in order to improve both binge eating and weight loss outcomes.
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA. Kerstin.Blomquist@Yale.Edu
Kerstin K
KK
Blomquist
Carlos M
CM
Grilo
D000328:Adult; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D056912:Binge-Eating Disorder / Q000188:drug therapy / Q000523:psychology* / Q000628:therapy*; D015928:Cognitive Behavioral Therapy; D004032:Diet; D005247:Feeding Behavior / Q000523:psychology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy / Q000523:psychology* / Q000628:therapy*; D000077403:Orlistat; D011237:Predictive Value of Tests; D012648:Self Care; D011795:Surveys and Questionnaires
D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat